McIlrath & Eck »

Athira Pharma shares owned by McIlrath & Eck

Quarter-by-quarter ownership of Athira Pharma shares owned by McIlrath & Eck from 13F filings

Historical chart of McIlrath & Eck investment in Athira Pharma

Tip: Access up to 7 years of quarterly data

All positions including Athira Pharma held by McIlrath & Eck consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Athira Pharma by McIlrath & Eck

Quarter filed Position value Share count Share price at filing
2025-12-31 $621 82 7.57
2025-09-30 $338 82 4.13

More positions owned by McIlrath & Eck

Vanguard Index Fds Growth Etf (VUG)
Ea Series Trust Strive Total Ret (STXT)
Vanguard Index Fds Value Etf (VTV)
Dimensional Etf Trust Short Duration F (DFSD)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
American Centy Etf Tr Avantis Us Mid C (AVMC)
Microsoft Corporation (MSFT)
Vanguard Index Fds Large Cap Etf (VV)
Fidelity Covington Trust High Divid Etf (FDVV)
Ea Series Trust Strive Enhanced (BUXX)
Ea Series Trust Strive Emerging (STXE)
Vanguard Whitehall Fds Em Mk Gov Bd Etf (VWOB)
Vanguard Index Fds Mid Cap Etf (VO)
Invesco Exch Traded Fd Tr Ii S&p Intl Momnt (IDMO)
Schwab Strategic Tr Intl Eqty Etf (SCHF)

View all positions for McIlrath & Eck

Top funds holding Athira Pharma

Perceptive Advisors
Acorn Capital Advisors
TCG Crossover Management
Commodore Capital
NEA Management Company
ADAR1 Capital Management
Vanguard Group
Propel Bio Management
Simplify Asset Management
Seven Fleet Capital Management
Renaissance Technologies
Pathstone Holdings
BlackRock
Acadian Asset Management
Citadel Advisors

View all funds holding Athira Pharma